Issue 7/2019
Time for a new definition of Parkinson’s disease
Content (13 Articles)
Time for a new definition of Parkinson’s disease
Wolfgang H. Jost, Heinz Reichmann
Biomarkers of Parkinson’s disease: 20 years later
Rezzak Yilmaz, Franziska Hopfner, Thilo van Eimeren, Daniela Berg
α-Synuclein in Parkinson’s disease: causal or bystander?
Peter Riederer, Daniela Berg, Nicolas Casadei, Fubo Cheng, Joseph Classen, Christian Dresel, Wolfgang Jost, Rejko Krüger, Thomas Müller, Heinz Reichmann, Olaf Rieß, Alexander Storch, Sabrina Strobel, Thilo van Eimeren, Hans-Ullrich Völker, Jürgen Winkler, Konstanze F. Winklhofer, Ullrich Wüllner, Friederike Zunke, Camelia-Maria Monoranu
Disease stage dependency of motor and non-motor fluctuations in Parkinson’s disease
Alexander Storch, Kristina Rosqvist, Georg Ebersbach, Per Odin
Hypersalivation: update of the German S2k guideline (AWMF) in short form
Armin Steffen, Wolfgang Jost, Tobias Bäumer, Dirk Beutner, Sabine Degenkolb-Weyers, Martin Groß, Maria Grosheva, Samer Hakim, Kai G. Kahl, Rainer Laskawi, Rebekka Lencer, Jan Löhler, Thekla Meyners, Saskia Rohrbach-Volland, Rainer Schönweiler, Sara-Christina Schröder, Sebastian Schröder, Heidrun Schröter-Morasch, Maria Schuster, Susanne Steinlechner, Roland Urban, Orlando Guntinas-Lichius
Sleep–wake and circadian disturbances in Parkinson disease: a short clinical guide
Christian R. Baumann
Polypharmacy in Parkinson’s disease: risks and benefits with little evidence
I. Csoti, H. Herbst, P. Urban, D. Woitalla, U. Wüllner
Dynamics of device-based treatments for Parkinson’s disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa–carbidopa intestinal gel, and deep brain stimulation
Daniel Richter, Dirk Bartig, Wolfgang Jost, Christoph Jörges, Britta Stumpe, Ralf Gold, Christos Krogias, Lars Tönges
Neuropsychiatric aspects of Parkinson’s disease
Anna Nagy, Anette Schrag
Mild cognitive impairment in Parkinson’s disease
Saul Martinez-Horta, Jaime Kulisevsky
Management of delirium in Parkinson’s disease
Georg Ebersbach, Chi Wang Ip, Stephan Klebe, Jiri Koschel, Stefan Lorenzl, Christoph Schrader, Christian Winkler, Christiana Franke
Evidence for the use of cannabinoids in Parkinson’s disease
Carsten Buhmann, Tina Mainka, Georg Ebersbach, Florin Gandor
Dyskinesia in multiple system atrophy and progressive supranuclear palsy
Wolfgang H. Jost, Paul Lingor, Lars Tönges, Johannes Schwarz, Carsten Buhmann, Jan Kassubek, Anette Schrag